Search research articles
Contact Us
Filters
Showing results (81-90 of 186) with videos related to
Page
of 19
Sort By:
Cancer Medicine
|
January 16, 2023
Changing incentives to ACCELERATE drug development for paediatric cancer
Teresa de Rojas, Pamela Kearns, Patricia Blanc, et al.
Pediatric Blood & Cancer
|
September 5, 2009
Clinical outcome in children with recurrent neuroblastoma treated with ABT-751 and effect of ABT-751 on proliferation of neuroblastoma cell lines and on tubulin polymerization in vitro
Holly J Meany, Dan L Sackett, John M Maris, et al.
Cancer Chemotherapy and Pharmacology
|
March 8, 2023
Entrectinib dose confirmation in pediatric oncology patients: pharmacokinetic considerations
Georgina Meneses-Lorente, Elena Guerini, Francois Mercier, et al.
JMIR Public Health and Surveillance
|
May 27, 2016
An Integrated Service Delivery Model to Identify Persons Living with HIV and to Provide Linkage to HIV Treatment and Care in Prioritized Neighborhoods: A Geotargeted, Program Outcome Study
Paula M Frew, Matthew Archibald, Jay Schamel, et al.
The Oncologist
|
July 1, 2008
Characteristics and outcome of pediatric patients enrolled in phase I oncology trials
Aerang Kim, Elizabeth Fox, Katherine Warren, et al.
Pediatric Blood & Cancer
|
April 28, 2017
A phase 1 study of the c-Met inhibitor, tivantinib (ARQ197) in children with relapsed or refractory solid tumors: A Children's Oncology Group study phase 1 and pilot consortium trial (ADVL1111)
James I Geller, John P Perentesis, Xiaowei Liu, et al.
Journal of the National Cancer Institute
|
March 26, 2026
FDA approvals for pediatric cancer indications using children's oncology group associated trials data
Margaret E Macy, Elizabeth Fox, Brenda J Weigel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 3, 2022
A Phase I/II Trial of Nivolumab plus Ipilimumab in Children and Young Adults with Relapsed/Refractory Solid Tumors: A Children's Oncology Group Study ADVL1412
Kara L Davis, Elizabeth Fox, Emasenyie Isikwei, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 9, 2017
Targeting ALK With Crizotinib in Pediatric Anaplastic Large Cell Lymphoma and Inflammatory Myofibroblastic Tumor: A Children's Oncology Group Study
Yael P Mossé, Stephan D Voss, Megan S Lim, et al.
Cancer Chemotherapy and Pharmacology
|
August 21, 2010
Plasma and CNS pharmacokinetics of O4-benzylfolic acid (O4BF) and metabolite in a non-human primate model
Meredith K Chuk, Diane E Cole, Cynthia McCully, et al.
Page
of 19
Search research articles
Search
Showing results (81-90 of 186) with videos related to
Sort By:
Page
of 19
Cancer Medicine
|
January 16, 2023
Changing incentives to ACCELERATE drug development for paediatric cancer
Teresa de Rojas, Pamela Kearns, Patricia Blanc, et al.
Pediatric Blood & Cancer
|
September 5, 2009
Clinical outcome in children with recurrent neuroblastoma treated with ABT-751 and effect of ABT-751 on proliferation of neuroblastoma cell lines and on tubulin polymerization in vitro
Holly J Meany, Dan L Sackett, John M Maris, et al.
Cancer Chemotherapy and Pharmacology
|
March 8, 2023
Entrectinib dose confirmation in pediatric oncology patients: pharmacokinetic considerations
Georgina Meneses-Lorente, Elena Guerini, Francois Mercier, et al.
JMIR Public Health and Surveillance
|
May 27, 2016
An Integrated Service Delivery Model to Identify Persons Living with HIV and to Provide Linkage to HIV Treatment and Care in Prioritized Neighborhoods: A Geotargeted, Program Outcome Study
Paula M Frew, Matthew Archibald, Jay Schamel, et al.
The Oncologist
|
July 1, 2008
Characteristics and outcome of pediatric patients enrolled in phase I oncology trials
Aerang Kim, Elizabeth Fox, Katherine Warren, et al.
Pediatric Blood & Cancer
|
April 28, 2017
A phase 1 study of the c-Met inhibitor, tivantinib (ARQ197) in children with relapsed or refractory solid tumors: A Children's Oncology Group study phase 1 and pilot consortium trial (ADVL1111)
James I Geller, John P Perentesis, Xiaowei Liu, et al.
Journal of the National Cancer Institute
|
March 26, 2026
FDA approvals for pediatric cancer indications using children's oncology group associated trials data
Margaret E Macy, Elizabeth Fox, Brenda J Weigel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 3, 2022
A Phase I/II Trial of Nivolumab plus Ipilimumab in Children and Young Adults with Relapsed/Refractory Solid Tumors: A Children's Oncology Group Study ADVL1412
Kara L Davis, Elizabeth Fox, Emasenyie Isikwei, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 9, 2017
Targeting ALK With Crizotinib in Pediatric Anaplastic Large Cell Lymphoma and Inflammatory Myofibroblastic Tumor: A Children's Oncology Group Study
Yael P Mossé, Stephan D Voss, Megan S Lim, et al.
Cancer Chemotherapy and Pharmacology
|
August 21, 2010
Plasma and CNS pharmacokinetics of O4-benzylfolic acid (O4BF) and metabolite in a non-human primate model
Meredith K Chuk, Diane E Cole, Cynthia McCully, et al.
Page
of 19